The University of Chicago Header Logo

Connection

Mark Kozloff to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Neoadjuvant Therapy.
Mark Kozloff
Connection Strength
0.018
Neoadjuvant Therapy
  1. SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer. Ann Oncol. 2010 Dec; 21(12):2370-2376.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.